Joel Ackerman, Chief Executive Officer at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 4,000 shares at $1.70 ($7K) on 2016-09-21, disclosed to the SEC on 2016-09-21.
Open-market purchase of $7k CSBR by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 1,000 | $2K | 24.3% |
| 2 | $1.64 | 1,000 | $2K | 24.5% |
| 3 | $1.70 | 1,000 | $2K | 25.4% |
| 4 | $1.73 | 1,000 | $2K | 25.8% |
| Total | $1.68 avg | 4,000 | $7K | 100% |
| Filing → |
| DVA | SELL | 2021-08-06 | $9.9M | — | Filing → |
| CSBR | SELL | 2018-10-03 | $767K | — | Filing → |
| CSBR | BUY | 2016-10-20 | $5K | — | Filing → |